Glenmark Pharmaceuticals expects innovative drugs to contribute a higher share of revenue as it shifts focus beyond generics, CMD Glenn Saldanha said.
Glenmark Pharmaceuticals expects innovative drugs to contribute a higher share of revenue as it shifts focus beyond generics, CMD Glenn Saldanha said.